BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23596225)

  • 1. What happens to older men after a screening test for prostate cancer?
    BMJ; 2013 Apr; 346():f2421. PubMed ID: 23596225
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical practice. Screening for prostate cancer.
    Hoffman RM
    N Engl J Med; 2011 Nov; 365(21):2013-9. PubMed ID: 22029754
    [No Abstract]   [Full Text] [Related]  

  • 3. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
    Barry MJ; Mulley AJ
    J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
    [No Abstract]   [Full Text] [Related]  

  • 4. What is the value of screening for prostate cancer in the US?
    Albertsen PC
    Nat Clin Pract Oncol; 2005 Nov; 2(11):536-7. PubMed ID: 16270077
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer screening; is this a teachable moment?
    Brawley OW
    J Natl Cancer Inst; 2009 Oct; 101(19):1295-7. PubMed ID: 19720970
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
    Welch HG; Schwartz LM; Woloshin S
    J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for prostate cancer.
    Brawley OW; Ankerst DP; Thompson IM
    CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution of serum prostate-specific antigen levels among American men: implications for prostate cancer prevalence and screening.
    Porter MP; Stanford JL; Lange PH
    Prostate; 2006 Jul; 66(10):1044-51. PubMed ID: 16598738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for prostate cancer - will we ever know?
    Adolfsson J
    Acta Oncol; 2010 Apr; 49(3):275-7. PubMed ID: 20397764
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.
    Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ
    J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer screening: is it possible to explain diametrically opposed views?
    Richardson A
    N Z Med J; 2005 Feb; 118(1209):U1289. PubMed ID: 15711622
    [No Abstract]   [Full Text] [Related]  

  • 13. Defining increased future risk for prostate cancer: evidence from a population based screening cohort.
    Schröder FH; Roobol MJ; Andriole GL; Fleshner N
    J Urol; 2009 Jan; 181(1):69-74; discussion 74. PubMed ID: 19012915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer in older men.
    Calabrese DA
    Urol Nurs; 2004 Aug; 24(4):258-64, 268; quiz 269. PubMed ID: 15446376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for prostate cancer among men 75 years of age or older.
    Barry MJ
    N Engl J Med; 2008 Dec; 359(24):2515-6. PubMed ID: 19073973
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing risk: does this patient have prostate cancer?
    Carter HB
    J Natl Cancer Inst; 2006 Apr; 98(8):506-7. PubMed ID: 16622114
    [No Abstract]   [Full Text] [Related]  

  • 17. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
    Zhu X; van Leeuwen PJ; Bul M; Otto SJ; de Koning HJ; Bangma CH; Schröder FH; Roobol MJ
    Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summaries for patients. Screening smarter, not harder, for prostate cancer.
    Ann Intern Med; 2013 Feb; 158(3):I-30. PubMed ID: 23381056
    [No Abstract]   [Full Text] [Related]  

  • 19. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.
    Hegarty JM; Wallace M; Comber H
    Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the diagnosis and management of prostate cancer.
    LaSpina M; Haas GP
    Can J Urol; 2008 Aug; 15 Suppl 1():3-13; discussion 13. PubMed ID: 18700060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.